Daewoong pharmaceutical

069620.KO

90.41 USD

-1.86

-2.02%

Overview

Last close

90.41 usd

Market cap

1.04B usd

52 week high

119.39 usd

52 week low

72.15 usd

Target price

139.12 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

1.0486

Price/Book Value

1.8639

Enterprise Value

1.41B usd

EV/Revenue

1.4158

EV/EBITDA

12.0675

Key financials

Revenue TTM

993.67M usd

Gross Profit TTM

508.21M usd

EBITDA TTM

129.01M usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

1.46B usd

Net debt

N/A usd

About

Daewoong Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in South Korea and internationally. It offers products in therapeutic areas, such as central nervous system, endocrinology, musculoskeletal, nephrology, antineoplastic, cardiovascular, gastrointestinal, metabolic, antiviral, analgesic, antacid, and digestive diseases, as well as wound, iron supplements, and muti-vitamins. The company also provides COVID-19 PCR kit, COVID-19 IgG/IgM RDT, and viral transport medium medical devices. The company was founded in 1945 and is headquartered in Seoul, South Korea.